The number of teens and young adults taking GLP-1 drugs has increased by 594 percent—but scientists are still trying to ...

Drug compounders aren’t ready to give up their ability to produce off-brand versions of Novo Nordisk’s weight-loss drug ...

Some health experts have call for further investigation, as figures show 82 deaths with suspected links to slimming drugs ...

A lawsuit challenges the FDA's decision to remove semaglutide from the shortage list, alleging it was arbitrary and harms ...

The MHRA reveals a staggering rise in deaths linked to weight loss and diabetes medications in the UK, with concerns over ...

Lars Fruergaard Jørgensen might not be a household name, but his company’s drug Ozempic is. And its success has thrust him — ...

People with a high body weight living in England can now access subsidised weight-loss drugs to treat their obesity.

When her consultant offered 20st Sarah a brand new injection called Ozempic that promised to treat her diabetes and help her ...

Hims & Hers stock drops 26% as FDA resolves semaglutide shortage, threatening GLP-1 revenue. Click here to find out why HIMS ...

Today we'll look at six European stocks that could continue outperforming in 2025. Some of these companies are available to ...

We recently published an article titled Two of 10 Worst-Performing Stocks Fall to All-Time Lows on Tuesday. In this article, ...